Search This Blog

Glimpses of ICD 10 CM New Codes - 2022

 ICD 10 CM New Code Description

A7982 Anaplasmosis [A. phagocytophilum]

C563 Malignant neoplasm of bilateral ovaries

C7963 Secondary malignant neoplasm of bilateral ovaries

C847A Anaplastic large cell lymphoma, ALK-negative, breast

D5521 Anemia due to pyruvate kinase deficiency

D5529 Anemia due to other disorders of glycolytic enzymes

D75838 Other thrombocytosis

D75839 Thrombocytosis, unspecified

D8944 Hereditary alpha tryptasemia

E75244 Niemann-Pick disease type A/B

F32A Depression, unspecified

F78A1 SYNGAP1-related intellectual disability

F78A9 Other genetic related intellectual disability

G0482 Acute flaccid myelitis

G4486 Cervicogenic headache

G9200 Immune effector cell-associated neurotoxicity syndrome, grade unspecified

G9201 Immune effector cell-associated neurotoxicity syndrome, grade 1

G9202 Immune effector cell-associated neurotoxicity syndrome, grade 2

G9203 Immune effector cell-associated neurotoxicity syndrome, grade 3

G9204 Immune effector cell-associated neurotoxicity syndrome, grade 4

G9205 Immune effector cell-associated neurotoxicity syndrome, grade 5

G928 Other toxic encephalopathy

G929 Unspecified toxic encephalopathy

I5A Non-ischemic myocardial injury (non-traumatic)

K2281 Esophageal polyp

K2282 Esophagogastric junction polyp

K2289 Other specified disease of esophagus

K31A0 Gastric intestinal metaplasia, unspecified

K31A11 Gastric intestinal metaplasia without dysplasia, involving the antrum

K31A12 Gastric intestinal metaplasia without dysplasia, involving the body (corpus)

K31A13 Gastric intestinal metaplasia without dysplasia, involving the fundus

K31A14 Gastric intestinal metaplasia without dysplasia, involving the cardia

K31A15 Gastric intestinal metaplasia without dysplasia, involving multiple sites

K31A19 Gastric intestinal metaplasia without dysplasia, unspecified site

K31A21 Gastric intestinal metaplasia with low grade dysplasia

K31A22 Gastric intestinal metaplasia with high grade dysplasia

K31A29 Gastric intestinal metaplasia with dysplasia, unspecified

L24A0 Irritant contact dermatitis due to friction or contact with body fluids, unspecified

L24A1 Irritant contact dermatitis due to saliva

L24A2 Irritant contact dermatitis due to fecal, urinary or dual incontinence

L24A9 Irritant contact dermatitis due friction or contact with other specified body fluids

L24B0 Irritant contact dermatitis related to unspecified stoma or fistula

L24B1 Irritant contact dermatitis related to digestive stoma or fistula

L24B2 Irritant contact dermatitis related to respiratory stoma or fistula

L24B3 Irritant contact dermatitis related to fecal or urinary stoma or fistula

M3110 Thrombotic microangiopathy, unspecified

M3111 Hematopoietic stem cell transplantation-associated thrombotic microangiopathy [HSCT-TMA]

M3119 Other thrombotic microangiopathy

M3505 Sjogren syndrome with inflammatory arthritis

M3506 Sjogren syndrome with peripheral nervous system involvement

M3507 Sjogren syndrome with central nervous system involvement

M3508 Sjogren syndrome with gastrointestinal involvement

M350A Sjogren syndrome with glomerular disease

M350B Sjogren syndrome with vasculitis

M350C Sjogren syndrome with dental involvement

M45A0 Non-radiographic axial spondyloarthritis of unspecified sites in spine

M45A1 Non-radiographic axial spondyloarthritis of occipito-atlanto-axial region

M45A2 Non-radiographic axial spondyloarthritis of cervical region

M45A3 Non-radiographic axial spondyloarthritis of cervicothoracic region

M45A4 Non-radiographic axial spondyloarthritis of thoracic region

M45A5 Non-radiographic axial spondyloarthritis of thoracolumbar region

M45A6 Non-radiographic axial spondyloarthritis of lumbar region

M45A7 Non-radiographic axial spondyloarthritis of lumbosacral region

M45A8 Non-radiographic axial spondyloarthritis of sacral and sacrococcygeal region

M45AB Non-radiographic axial spondyloarthritis of multiple sites in spine

M5450 Low back pain, unspecified

M5451 Vertebrogenic low back pain

M5459 Other low back pain

P0082 Newborn affected by (positive) maternal group B streptococcus (GBS) colonization

P091 Abnormal findings on neonatal screening for inborn errors of metabolism

P092 Abnormal findings on neonatal screening for congenital endocrine disease

P093 Abnormal findings on neonatal screening for congenital hematologic disorders

P094 Abnormal findings on neonatal screening for cystic fibrosis

P095 Abnormal findings on neonatal screening for critical congenital heart disease

P096 Abnormal findings on neonatal screening for neonatal hearing loss

P098 Other abnormal findings on neonatal screening

P099 Abnormal findings on neonatal screening, unspecified

R051 Acute cough

R052 Sub acute cough

R053 Chronic cough

R054 Cough syncope

R058 Other specified cough

R059 Cough, unspecified

R3581 Nocturnal polyuria

R3589 Other polyuria

R4588 Non suicidal self-harm

R6330 Feeding difficulties, unspecified

R6331 Pediatric feeding disorder, acute

R6332 Pediatric feeding disorder, chronic

R6339 Other feeding difficulties

R7983 Abnormal findings of blood amino-acid level

S06A0XA Traumatic brain compression without herniation, initial encounter

S06A0XD Traumatic brain compression without herniation, subsequent encounter

S06A0XS Traumatic brain compression without herniation, sequela

S06A1XA Traumatic brain compression with herniation, initial encounter

S06A1XD Traumatic brain compression with herniation, subsequent encounter

S06A1XS Traumatic brain compression with herniation, sequela

T40711A Poisoning by cannabis, accidental (unintentional), initial encounter

T40711D Poisoning by cannabis, accidental (unintentional), subsequent encounter

T40711S Poisoning by cannabis, accidental (unintentional), sequela

T40712A Poisoning by cannabis, intentional self-harm, initial encounter

T40712D Poisoning by cannabis, intentional self-harm, subsequent encounter

T40712S Poisoning by cannabis, intentional self-harm, sequela

T40713A Poisoning by cannabis, assault, initial encounter

T40713D Poisoning by cannabis, assault, subsequent encounter

T40713S Poisoning by cannabis, assault, sequela

T40714A Poisoning by cannabis, undetermined, initial encounter

T40714D Poisoning by cannabis, undetermined, subsequent encounter

T40714S Poisoning by cannabis, undetermined, sequela

T40715A Adverse effect of cannabis, initial encounter

T40715D Adverse effect of cannabis, subsequent encounter

T40715S Adverse effect of cannabis, sequela

T40716A Underdosing of cannabis, initial encounter

T40716D Underdosing of cannabis, subsequent encounter

T40716S Underdosing of cannabis, sequela

T40721A Poisoning by synthetic cannabinoids, accidental (unintentional), initial encounter

T40721D Poisoning by synthetic cannabinoids, accidental (unintentional), subsequent encounter

T40721S Poisoning by synthetic cannabinoids, accidental (unintentional), sequela

T40722A Poisoning by synthetic cannabinoids, intentional self-harm, initial encounter

T40722D Poisoning by synthetic cannabinoids, intentional self-harm, subsequent encounter

T40722S Poisoning by synthetic cannabinoids, intentional self-harm, sequela

T40723A Poisoning by synthetic cannabinoids, assault, initial encounter

T40723D Poisoning by synthetic cannabinoids, assault, subsequent encounter

T40723S Poisoning by synthetic cannabinoids, assault, sequela

T40724A Poisoning by synthetic cannabinoids, undetermined, initial encounter

T40724D Poisoning by synthetic cannabinoids, undetermined, subsequent encounter

T40724S Poisoning by synthetic cannabinoids, undetermined, sequela

T40725A Adverse effect of synthetic cannabinoids, initial encounter

T40725D Adverse effect of synthetic cannabinoids, subsequent encounter

T40725S Adverse effect of synthetic cannabinoids, sequela

T40726A Underdosing of synthetic cannabinoids, initial encounter

T40726D Underdosing of synthetic cannabinoids, subsequent encounter

T40726S Underdosing of synthetic cannabinoids, sequela

T8082XA Complication of immune effector cellular therapy, initial encounter

T8082XD Complication of immune effector cellular therapy, subsequent encounter

T8082XS Complication of immune effector cellular therapy, sequela

U099 Post COVID-19 condition, unspecified

Y35899A Legal intervention involving other specified means, unspecified person injured, initial encounter

Y35899D Legal intervention involving other specified means, unspecified person injured, subsequent encounter

Y35899S Legal intervention involving other specified means, unspecified person injured, sequela

Z555 Less than a high school diploma

Z586 Inadequate drinking-water supply

Z5900 Homelessness unspecified

Z5901 Sheltered homelessness

Z5902 Unsheltered homelessness

Z5941 Food insecurity

Z5948 Other specified lack of adequate food

Z59811 Housing instability, housed, with risk of homelessness

Z59812 Housing instability, housed, homelessness in past 12 months

Z59819 Housing instability, housed unspecified

Z5989 Other problems related to housing and economic circumstances

Z7185 Encounter for immunization safety counseling

Z91014 Allergy to mammalian meats

Z9151 Personal history of suicidal behavior

Z9152 Personal history of non suicidal self-harm

Z92850 Personal history of Chimeric Antigen Receptor T-cell therapy

Z92858 Personal history of other cellular therapy

Z92859 Personal history of cellular therapy, unspecified

Z9286 Personal history of gene therapy


 

No comments:

ICD 10 CM Updates

Flu Season Vaccine Updates - 2024-2025

For the 2024-2025 flu season in the United States, all vaccines are expected to be trivalent.  These trivalent vaccines are designed to prot...